Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Ikena Oncology, Inc. Income Statement Banner

Ikena Oncology, Inc. Income Statement

IKNA Stock Analysis

Page title

Section title

Breakdown
2018
2019
2020
2021
2022
2023
Total Revenue
990.000K13.753M9.194M30.985M15.618M9.160M
Cost of Revenue
38.986M24.938M44.847M47.108M2.034M1.020M
Gross Profit
-37.996m-11.185m-35.653m-16.123m13.584M8.140M
Operating Expense
41.462M32.245M53.713M65.123M86.522M83.557M
Operating Income
-40.894m-18.492m-44.519m-34.138m-70.904m-75.417m
Other Income Expense
0.0001.675M263.000K23.000K-10.000k-22.000k
Total Other Income Expense
29.000K1.675M263.000K23.000K2.139M7.089M
Pretax Income
-40.865m-16.817m-44.256m-34.115m-68.765m-68.328m
Tax Provision
0.00071.140K93.703K307.442K-2.139m-162.000k
Net Income
-40.865m-16.817m-44.256m-34.115m-66.626m-68.166m
Basic EPS
-1.140-0.470-1.230-0.950-1.840-1.630
Diluted EPS
-1.140-0.470-1.230-0.950-1.840-1.630
Basic Average Shares
35.851M35.851M35.851M35.975M36.188M41.735M
Diluted Average Shares
35.851M35.851M35.851M35.975M36.188M41.735M
Total Expenses
41.884M32.245M53.713M65.123M86.522M84.577M
Interest Income
0.0000.0000.00023.000K2.149M7.111M
Interest Expense
0.0000.0000.0000.0002.149M0.000
EBITDA
-40.472m-18.249m-44.219m-33.594m-70.153m-74.397m
Depreciation & Amortization
422.000K122.000K1.264M1.718M2.034M1.020M